BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 19075904)

  • 1. Potential of microemulsions in drug delivery and therapeutics: a patent review.
    Bali V; Bhavna ; Ali M; Baboota S; Ali J
    Recent Pat Drug Deliv Formul; 2008; 2(2):136-44. PubMed ID: 19075904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microemulsions: a novel approach to enhanced drug delivery.
    Talegaonkar S; Azeem A; Ahmad FJ; Khar RK; Pathan SA; Khan ZI
    Recent Pat Drug Deliv Formul; 2008; 2(3):238-57. PubMed ID: 19075911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microemulsions: a potential drug delivery system.
    Ghosh PK; Murthy RS
    Curr Drug Deliv; 2006 Apr; 3(2):167-80. PubMed ID: 16611003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microemulsion systems containing bioactive natural oils: an overview on the state of the art.
    Xavier-Junior FH; Vauthier C; Morais AR; Alencar EN; Egito ES
    Drug Dev Ind Pharm; 2017 May; 43(5):700-714. PubMed ID: 27622950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A critical appraisal of microemulsions for drug delivery: part I.
    Sapra B; Thatai P; Bhandari S; Sood J; Jindal M; Tiwary A
    Ther Deliv; 2013 Dec; 4(12):1547-64. PubMed ID: 24304251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microemulsions as potential drug delivery systems: a review.
    Ansari MJ; Kohli K; Dixit N
    PDA J Pharm Sci Technol; 2008; 62(1):66-79. PubMed ID: 18402369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microemulsions: a potential delivery system for bioactives in food.
    Flanagan J; Singh H
    Crit Rev Food Sci Nutr; 2006; 46(3):221-37. PubMed ID: 16527754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved drug delivery using microemulsions: rationale, recent progress, and new horizons.
    Bagwe RP; Kanicky JR; Palla BJ; Patanjali PK; Shah DO
    Crit Rev Ther Drug Carrier Syst; 2001; 18(1):77-140. PubMed ID: 11326744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of microemulsions in dermal and transdermal drug delivery.
    Santos P; Watkinson AC; Hadgraft J; Lane ME
    Skin Pharmacol Physiol; 2008; 21(5):246-59. PubMed ID: 18562799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Basics of Compounding: Compounding Microemulsions.
    Allen LV
    Int J Pharm Compd; 2018; 22(2):137-143. PubMed ID: 29877861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microemulsion utility in pharmaceuticals: Implications for multi-drug delivery.
    Callender SP; Mathews JA; Kobernyk K; Wettig SD
    Int J Pharm; 2017 Jun; 526(1-2):425-442. PubMed ID: 28495500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microemulsion-based media as novel drug delivery systems.
    Lawrence MJ; Rees GD
    Adv Drug Deliv Rev; 2000 Dec; 45(1):89-121. PubMed ID: 11104900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microemulsions for oral administration and their therapeutic applications.
    Gibaud S; Attivi D
    Expert Opin Drug Deliv; 2012 Aug; 9(8):937-51. PubMed ID: 22663249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimized mixed oils remarkably reduce the amount of surfactants in microemulsions without affecting oral bioavailability of ibuprofen by simultaneously enlarging microemulsion areas and enhancing drug solubility.
    Chen Y; Tuo J; Huang H; Liu D; You X; Mai J; Song J; Xie Y; Wu C; Hu H
    Int J Pharm; 2015 Jun; 487(1-2):17-24. PubMed ID: 25841571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimizing surfactant content to improve oral bioavailability of ibuprofen in microemulsions: just enough or more than enough?
    You X; Xing Q; Tuo J; Song W; Zeng Y; Hu H
    Int J Pharm; 2014 Aug; 471(1-2):276-84. PubMed ID: 24858390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microemulsions as drug delivery systems to improve the solubility and the bioavailability of poorly water-soluble drugs.
    He CX; He ZG; Gao JQ
    Expert Opin Drug Deliv; 2010 Apr; 7(4):445-60. PubMed ID: 20201713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microemulsions as a surrogate carrier for dermal drug delivery.
    Azeem A; Khan ZI; Aqil M; Ahmad FJ; Khar RK; Talegaonkar S
    Drug Dev Ind Pharm; 2009 May; 35(5):525-47. PubMed ID: 19016057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of excipients in successful development of self-emulsifying/microemulsifying drug delivery system (SEDDS/SMEDDS).
    Rahman MA; Hussain A; Hussain MS; Mirza MA; Iqbal Z
    Drug Dev Ind Pharm; 2013 Jan; 39(1):1-19. PubMed ID: 22372916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microstructured bicontinuous phase formulations: their characterization and application in dermal and transdermal drug delivery.
    Lapteva M; Kalia YN
    Expert Opin Drug Deliv; 2013 Aug; 10(8):1043-59. PubMed ID: 23600804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current Trends in Self-Emulsifying Drug Delivery Systems (SEDDSs) to Enhance the Bioavailability of Poorly Water-Soluble Drugs.
    Karwal R; Garg T; Rath G; Markandeywar TS
    Crit Rev Ther Drug Carrier Syst; 2016; 33(1):1-39. PubMed ID: 27279337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.